Baby / Myeloma / Hospital / Cancer

Top in hem/onc: COVID-19 and VTE risk, CAR T-cell therapy approval

Posted on: Apr 8, 2021   |   Posted by: Health Mag

Top in hem/onc: COVID-19 and VTE risk, CAR T-cell therapy approval

Researchers in China identified an increased risk for symptomatic venous thromboembolism in patients hospitalized with COVID-19. It was the top story in hematology/oncology...

Continue reading ...



Other Posts from Health Mag